Hoxworth Blood Center returns to Cincinnati Playhouse in the Park for the 26th annual blood drive
Hoxworth Blood Center, University of Cincinnati, and Cincinnati Playhouse in the Park, are excited to announce the return of the annual Cincinnati Playhouse in the Park blood drive on November 18, 2023.
The blood drive will be held in the new Schueler Lobby at Cincinnati Playhouse in the Park (962 Mt. Adams Circle, Cincinnati, OH 45202), on Saturday, November 18 from 8am – 2pm. All donors will receive a voucher for half-priced tickets for a Tuesday-Friday evening performance of Dracula. Available performances begin February 6 - March 1, 2024.
“We are excited to partner with Hoxworth Blood Center once again and host the blood drive in our brand-new facility for the first time,” says Bridget Siedlecki, director of operations. “We hope that discount tickets to our world premiere production of Dracula will encourage many people to give blood.”
Hoxworth’s goal is to schedule at least 110 whole blood and red cell donors during this special event to help ensure a stable blood supply heading into the holiday season where they tend to see a drop in blood donations. 450 donors are needed daily to meet the demand of local hospitals.
Appointments are highly encouraged due to the popularity of this event; however, walk-ins are welcome as the schedule allows. To schedule a donation for the Playhouse in the Park blood drive, visit hoxworth.org/groups/playhouse or call 513-451-0910.
About Hoxworth:
Hoxworth Blood Center, University of Cincinnati, was founded in 1938, and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.